Neuland Laboratories Ltd Q1 FY2024 consolidated PAT falls QoQ to Rs. 61.87 crores

Neuland Laboratories Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 365.0328 crores during the period ended June 30, 2023 as compared to Rs. 415.1368 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 61.8790 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 84.5439 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 48.23 for the period ended June 30, 2023 as compared to Rs. 65.90 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 365.0328 crs	₹415.1368 crs	-12.07%
Net Profit	₹61.8790 crs	₹84.5439 crs	-26.81%
EPS	₹48.23	₹65.90	-26.81%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 365.0328 crores during the period ended June 30, 2023 as compared to Rs.221.6817 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.61.8790 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.9.9658 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.48.23 for the period ended June 30, 2023 as compared to Rs.7.77 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 365.0328 crs	₹221.6817 crs	64.67%
Net Profit	₹61.8790 crs	₹9.9658 crs	520.91%
EPS	₹48.23	₹7.77	520.72%

Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 3559.85 as compared to the previous close of Rs. 3448.15. The total number of shares traded during the day was 16981 in over 3500 trades.

The stock hit an intraday high of Rs. 3692.40 and intraday low of 3350.95. The net turnover during the day was Rs. 59854653.00.

Source : Equity Bulls

Keywords

NeulandLaboratories Q1FY24 ResultUpdate